Natick, MASSACHUSETTS – July 16, 2019 – ABI-LAB, a biotech incubator facility firm, announced the launch of an acceleration office hours program with Alira Health to benefit current residents. ABI-LAB is an accelerator and bio-incubator established to support startups, including life science, biotech, medical technology, and medical data companies.
Please join me in congratulating Karyopharm Therapeutics. Karyopharm Therapeutics, on July 3rd, 2019 was granted FDA approval for its Multiple Myeloma Drug, Xpovio. Dr. Raphael Nir helped foster and conduct early research stages through SBH Sciences drug optimization services.